0.00Open0.00Pre Close0 Volume0 Open Interest240.00Strike Price0.00Turnover189.35%IV-18.69%PremiumNov 1, 2024Expiry Date37.79Intrinsic Value100Multiplier1DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.9448Delta0.0054Gamma5.35Leverage Ratio-0.4450Theta-0.0056Rho-5.05Eff Leverage0.0123Vega
AbbVie Stock Discussion
$E-mini S&P 500 Futures(DEC4) (ESmain.US)$ (4 Hour Chart) -[BULLISH↗ *]We stay bullish as long as price holds above 5815 support level. We expect price to push towards 5930 resistance level. A 4 hour candlestick closing above 5930 resistance level would open next push towards 5990 resistance level. Technical indicators are mixed, with prices holding above 21-EMA period.
Alternatively: A 4 hour candlestick c...
The move surpassed Wall Street's expectations. Analysts had generally anticipated a 25 basis point cut, while the futures market had priced in a 61% probability of a 50 basis point cut and a 39% probability of a 25 basis point reduction.
Market Response to First Rate Cut
St...
Notably, several stocks within these sectors have shown exceptional performance. Pharmaceutical giants with market values in the hundreds of billions, such as $Eli Lilly and Co (LLY.US)$, $Thermo Fisher Scientific (TMO.US)$, $AbbVie (ABBV.US)$, and ...
loading...
📊⚡️📊
$Alphabet-A (GOOGL.US)$, the parent company of Google, is expected to report revenue of $84.3bn and net income of $23bn, or $1.85 per share, in ...
EPKINLY (Epcoritamab) Now Approved for Patients w/ Follicular Lymphoma (FL)
» Positive results in Ph1/2 EPCORE® NHL-1 study for R/R FL
» Offers off-the-shelf T-cell therapy
» First-of-its-kind antibody for both R/R FL & DLBCL after prior treatments (2+ lines)
No comment yet